Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
NCT00095108
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Kidney Neoplasms
Metastases
Interventions
DRUG:
Recombinant Human Interleukin-21
Sponsor
ZymoGenetics